1. Home
  2. Analysis and guidance
  3. Laboratory diagnosis and molecular surveillance of Bordetella pertussis

Laboratory diagnosis and molecular surveillance of Bordetella pertussis

Guidance
21 Dec 2022
Cite:

European Centre for Disease Prevention and Control. Laboratory diagnosis and molecular
surveillance of Bordetella pertussis - Stockholm: ECDC; 2022.

This guidance document includes an updated summary of diagnostic PCR and serology together with detailed information on isolation, culture, identification and epidemiological typing of B. pertussis to help users choose the best methods within the local technical and financial provisions.

Download

Cover of the report: "Laboratory diagnosis and molecular surveillance of Bordetella pertussis"
Laboratory diagnosis and molecular surveillance of Bordetella pertussis - EN - [PDF-2.06 MB]

More on this topic

Thumbnail

Microbiology of pertussis

ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.

Read more